S-EGFR was markedly higher in the group of breast cancer patients than in healthy women, and, when evaluating against age-dependent 95% reference intervals33, we found that 11.3% of the breast cancer patients had elevated S-EGFR values. This evidence concerns the gene EGFR and breast carcinoma.